Collaboration

In the vibrant city of Dakar, Senegal, October marked a significant convergence of minds committed to tackling the world's health challenges. Among the esteemed attendees of the Grand Challenges Annual Meeting (GCAM) 2023 October 9-13th, 2023,  were key members from the University of Nairobi's Department of Medical Microbiology and Immunology: Dr. Marianne Mureithi, Prof. Omu Anzala, and Dr. Daniel Muema.

The Historic First Face-to-Face Meeting of ECC Teams in Nairobi and Helsinki
KAVI-Boardroom, Nairobi – 16th August 2023

The Department of Medical Microbiology & Immunology were delighted to welcome Carey Farquhar, MD, MPH from the University of Washington in Seattle, USA.

Professor Pier Paolo Piccaluga paid a courtesy visit to Department Chair Dr. Marianne Mureithi on the 24th of July 2023.

Prof. R. Scott McClelland of the University of Washington delivered a special lecture on Sexually Transmitted Infections (STIs) to MSc students from the Department of Medical Microbiology & Immunology on the 11th of July.

Dr. Marianne Mureithi has been appointed as an Affiliate Associate Professor in the Department of Global Health at the School of Public Health, University of Washington effective from 1st of July 2023.

Nairobi, Kenya, May 29th, 2023 - The KAVI-Institute of Clinical Research had the honor of hosting a team from the International Vaccine Institute (IVI). The team from IVI paid a courtesy visit to the Institute to establish potential research project collaborations.

James Kang'ethe, a PhD scholar in the Department of Medical Microbiology and Immunology at the University of Nairobi, recently attended the African Advanced Vaccinology Course (Afro-ADVAC) held in Muldersdrift, Gauteng, South Africa. James, a CARTA cohort 10 fellow, participated in the course between April 17 - 26, 2023.

The African Caribbean Cancer Consortium (AC3) won the American Association for Cancer Research (AACR) Team Science Award at the AACR Annual Meeting in Orlando, Florida.

As stated by the AACR, "This award recognizes an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or likely will advance our fundamental knowledge of cancer, or a team that has applied existing knowledge to advance the detection, diagnosis, prevention, or treatment of cancer."